lexi
IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1457 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


This article has been cited by
1Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus
Bindu Chamarthi,J. Michael Gaziano,Lawrence Blonde,Aaron Vinik,Richard E. Scranton,Michael Ezrokhi,Dean Rutty,Anthony H. Cincotta
Journal of Diabetes Research.2015;2015()1
[DOI]
2Di-peptidyl peptidase-4 inhibitor sitagliptin protects vascular function in metabolic syndrome: possible role of epigenetic regulation
Cicek Figen Amber,Tokcaer-Keskin Zeynep,Ozcinar Evren,Bozkus Yusuf,Akcali Kamil Can,Turan Belma
Molecular Biology Reports.2014;41(8)4853
[DOI]
3The effect of 2-month bromocriptine treatment on the activity of the adenylyl cyclase signaling system in the myocardium and testes of rats with type 2 diabetes
K. V. Derkach,V. M. Bondareva,I. V. Moiseyuk,A. O. Shpakov
Cell and Tissue Biology.2015;9(5)395
[DOI]
4Bromocriptine therapy: Review of mechanism of action, safety and tolerability
Faiza Naz,Abdul Malik,Muhammad Riaz,Qaisar Mahmood,Malik Hassan Mehmood,Ghulam Rasool,Zahed Mahmood,Mazhar Abbas
Clinical and Experimental Pharmacology and Physiology.2022;9(5)395
[DOI]
5Arginine and aerobic training prevent endothelial and metabolic alterations in rats at high risk for the development of the metabolic syndrome
Renata F. Medeiros,Thaiane G. Gaique,Thais Bento-Bernardes,Raquel Kindlovits,Tamiris M. B. Gomes,Nadia Alice V. Motta,Fernanda Carla Brito,Caroline Fernandes-Santos,Karen J. Oliveira,Antonio Claudio L. Nˇbrega
British Journal of Nutrition.2017;118(1)1
[DOI]
6Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases
Alexander O Shpakov,Kira V Derkach,Lev M Berstein
Future Science OA.2015;1(3)1
[DOI]
7The effect of prolonged intranasal administration of serotonin on the activity of hypothalamic signaling systems in male rats with neonatal diabetes
I. B. Sukhov,K. V. Derkach,O. V. Chistyakova,V. M. Bondareva,A. O. Shpakov
Cell and Tissue Biology.2016;10(4)314
[DOI]
8Bromocriptine treatment at the end of lactation prevents hyperphagia, higher visceral fat and liver triglycerides in early-weaned rats at adulthood
Nayara Peixoto-Silva,Egberto G Moura,Janaine C Carvalho,JÚssica L Nobre,Fernanda T Quitete,Cintia R Pinheiro,Ana Paula Santos-Silva,Elaine de Oliveira,Patricia C Lisboa
Clinical and Experimental Pharmacology and Physiology.2017;44(4)488
[DOI]
9Review of a causal role of fructose-containing sugars in myocardial susceptibility to ischemia/reperfusion injury
Gerald J. Maarman,Amy E. Mendham,Kim Lamont,Cindy George
Nutrition Research.2017;42(4)11
[DOI]
10Restoration of hypothalamic signaling systems as a cause of improved metabolic parameters in rats with neonatal diabetes model during treatment with bromocriptine mesylate
K. V. Derkach,A. O. Ivantsov,I. B. Sukhov,A. O. Shpakov
Cell and Tissue Biology.2017;11(3)234
[DOI]
11The Effect of Long-Term Intranasal Serotonin Treatment on Metabolic Parameters and Hormonal Signaling in Rats with High-Fat Diet/Low-Dose Streptozotocin-Induced Type 2 Diabetes
Kira V. Derkach,Vera M. Bondareva,Oxana V. Chistyakova,Lev M. Berstein,Alexander O. Shpakov
International Journal of Endocrinology.2015;2015(3)1
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow